Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

The impact of age on risk assessment, therapeutic practice and outcome in candidemia.

Hesstvedt L, Gaustad P, Müller F, Torp Andersen C, Brunborg C, Mylvaganam H, Leiva RA, Erik Berdal J, Egil Ranheim T, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Sandmo Lyngøy A, Wik Larssen K, Hannula R, Åsheim Hansen B, Nordøy I; Norwegian Fungal Network.

Infect Dis (Lond). 2019 Jun;51(6):425-434. doi: 10.1080/23744235.2019.1595709. Epub 2019 Apr 23.

PMID:
31010380
2.

Exploring the arthritogenicity of Streptococcus dysgalactiae subspecies equisimilis.

Oppegaard O, Mylvaganam H, Skrede S, Kittang BR.

BMC Microbiol. 2018 Feb 27;18(1):17. doi: 10.1186/s12866-018-1160-5.

3.

An Estimate of the Burden of Fungal Disease in Norway.

Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW.

J Fungi (Basel). 2018 Feb 21;4(1). pii: E29. doi: 10.3390/jof4010029.

4.

Emergence of a Streptococcus dysgalactiae subspecies equisimilis stG62647-lineage associated with severe clinical manifestations.

Oppegaard O, Mylvaganam H, Skrede S, Lindemann PC, Kittang BR.

Sci Rep. 2017 Aug 8;7(1):7589. doi: 10.1038/s41598-017-08162-z.

5.

Clinical and molecular characteristics of infective β-hemolytic streptococcal endocarditis.

Oppegaard O, Mylvaganam H, Skrede S, Jordal S, Glambek M, Kittang BR.

Diagn Microbiol Infect Dis. 2017 Oct;89(2):135-142. doi: 10.1016/j.diagmicrobio.2017.06.015. Epub 2017 Jun 30.

PMID:
28780243
6.

Aetiology and clinical features of facial cellulitis: a prospective study.

Rath E, Skrede S, Mylvaganam H, Bruun T.

Infect Dis (Lond). 2018 Jan;50(1):27-34. doi: 10.1080/23744235.2017.1354130. Epub 2017 Aug 2.

PMID:
28768452
7.

Extended spectrum cephalosporin resistance among clinical isolates of Enterobacteriaceae in West Norway during 2006-2013; a prospective surveillance study.

Mylvaganam H, Kolstad H, Breistein RI, Lind G, Skutlaberg DH.

APMIS. 2017 Jan;125(1):52-58. doi: 10.1111/apm.12631. Epub 2016 Dec 6.

PMID:
27921337
8.

Temporal trends of β-haemolytic streptococcal osteoarticular infections in western Norway.

Oppegaard O, Skrede S, Mylvaganam H, Kittang BR.

BMC Infect Dis. 2016 Oct 4;16(1):535.

9.

H. Onarheim og medarbeidere svarer.

Onarheim H, Brekke RL, Leiva RA, Oma DH, Kolstad H, Samuelsen Ø, Sundsfjord A, Mylvaganam H.

Tidsskr Nor Laegeforen. 2016 Sep 27;136(17):1424-5. doi: 10.4045/tidsskr.16.0755. eCollection 2016 Sep. Norwegian. No abstract available.

10.

A patient with sepsis following a burn injury in Pakistan.

Onarheim H, Brekke RL, Leiva RA, Oma DH, Kolstad H, Samuelsen Ø, Sundsfjord A, Mylvaganam H.

Tidsskr Nor Laegeforen. 2016 Aug 23;136(14-15):1228-32. doi: 10.4045/tidsskr.15.1208. eCollection 2016 Aug. English, Norwegian. No abstract available.

11.

Etiology of Cellulitis and the Validity of New and Old Methods.

Bruun T, Oppegaard O, Kittang BR, Mylvaganam H, Langeland N, Skrede S.

Clin Infect Dis. 2016 Apr 1;62(7):954-5. doi: 10.1093/cid/ciw003. Epub 2016 Jan 6. No abstract available.

PMID:
26743089
12.

Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study.

Bruun T, Oppegaard O, Kittang BR, Mylvaganam H, Langeland N, Skrede S.

Open Forum Infect Dis. 2015 Nov 25;3(1):ofv181. doi: 10.1093/ofid/ofv181. eCollection 2016 Jan.

13.

Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infections.

Siemens N, Kittang BR, Chakrakodi B, Oppegaard O, Johansson L, Bruun T, Mylvaganam H; INFECT Study Group, Svensson M, Skrede S, Norrby-Teglund A.

Sci Rep. 2015 Nov 25;5:16945. doi: 10.1038/srep16945.

14.

[Aminoglycosides should still be used in empirical sepsis treatment].

Lindemann PC, Haldorsen BC, Smith I, Sjursen H, Mylvaganam H.

Tidsskr Nor Laegeforen. 2013 May 28;133(10):1054-5. doi: 10.4045/tidsskr.13.0213. Norwegian. No abstract available.

15.

Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.

Lindemann PC, Risberg K, Wiker HG, Mylvaganam H.

APMIS. 2012 Jun;120(6):495-502. doi: 10.1111/j.1600-0463.2011.02856.x. Epub 2011 Dec 19.

PMID:
22583362
16.

Proteomic analysis of a multi-resistant clinical Escherichia coli isolate of unknown genomic background.

Tomazella GG, Risberg K, Mylvaganam H, Lindemann PC, Thiede B, Souza GA, Wiker HG.

J Proteomics. 2012 Mar 16;75(6):1830-7. doi: 10.1016/j.jprot.2011.12.024. Epub 2011 Dec 30.

PMID:
22236517
17.

Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in Dar es Salaam, Tanzania.

Moyo SJ, Gro N, Matee MI, Kitundu J, Myrmel H, Mylvaganam H, Maselle SY, Langeland N.

BMC Pediatr. 2011 Feb 23;11:19. doi: 10.1186/1471-2431-11-19.

18.

Clinical, microbiological and molecular characteristics of six cases of group A streptococcal meningitis in western Norway.

Bruun T, Kittang BR, Mylvaganam H, Lund-Johansen M, Skrede S.

Scand J Infect Dis. 2010 Sep;42(9):665-71. doi: 10.3109/00365548.2010.483477.

PMID:
20465489
19.

Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden.

Karah N, Poirel L, Bengtsson S, Sundqvist M, Kahlmeter G, Nordmann P, Sundsfjord A, Samuelsen Ø; Norwegian Study Group on PMQR.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):425-31. doi: 10.1016/j.diagmicrobio.2009.12.004.

PMID:
20226333
20.

Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis.

Kittang BR, Langeland N, Skrede S, Mylvaganam H.

J Clin Microbiol. 2010 Apr;48(4):1484-7. doi: 10.1128/JCM.01737-09. Epub 2010 Feb 10.

Supplemental Content

Loading ...
Support Center